Cite Filings / ENTA / 0001567619-19-002908
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

ENANTA PHARMACEUTICALS INC · Filed 2019-02-11 · Acc 0001567619-19-002908

Documents 1

  • SC 13G/A Amended Statement of Ownership , doc1.htm

Around this filing

  • 2019-02-14 SC 13G/A Amended Statement of Ownership
  • 2019-02-13 4 Senior Vice President gave up 4,580 shares (to pay taxes)
  • 2019-02-13 4 Sr. VP & Chief Medical Officer gave up 5,356 shares (to pay taxes)
  • 2019-02-13 4 Sr. VP & General Counsel sold 3,270 shares at $95.28 ($311,562)
  • 2019-02-11 SC 13G/A Amended Statement of Ownership
  • 2019-02-11 SC 13G Amended Statement of Ownership
  • 2019-02-08 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · ADAR1 Capital Management, LLC 6.0%
  2. 2026-11-16 SCHEDULE 13G/A · Farallon Capital Management, L.L.C. 3.3%
Loading doc1.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…